№ 2 (2022): Nashr
67-71
2022-10-31
Ochiq kirish

КЛИНИКО-НЕВРОЛОГИЧЕСКИЕ И НЕЙРОФИЗИОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ У ДЕТЕЙ С ТРИСОМИЕЙ 21 ХРОМОСОМЫ

S.M. Salikhova
Y.N. Majidova

Qabul qilingan: 2022-11-10

Nashr etilgan: 2022-10-31

PDF (ruscha)

Annotatsiya

Синдром Дауна – самая распространенная хромосомная патология. Она возникает, когда в результате
случайной мутации в 21-й паре появляется еще одна хромосома. Зачастую дети с синдромом Дауна (СД) и
сопутствующими нарушениями имеют более низкий уровень IQ, тяжелые формы стереотипного поведения.
Цель исследования: изучение неврологических состояний у детей с СД. Проведение клинико-неврологических,
нейрофизиологических и аудиологических исследованиий у 34 детей (16 мальчиков, 18 девочек) с СД. Для
определения интеллектуального статуса у детей с СД использовалась шкала Стэнфорд-Бине. Проявление
аутистических расстройств, соматическая патология, отсутствие речевой активности являются
неблагоприятными прогностическими факторами у детей с СД.

Kalit so‘zlar

Adabiyotlar ro'yxati

  1. Madjidova Ya.N., Salikhova S.M.: Possible pathogenetic mechanisms of progression and the occurrence of intellectual and cognitive impairment in patients with Down syndrome, International Journal of Psychosocial and Rehabilitation, Scopus. -2020. -Vol.24, special issue 1. -P. 789-793.

  2. Uryadnitskaya Natalia Anatolyevna / Down syndrome: features of neuroanatomy / Journal "Down Syndrome. XXI century”. - 2012. -Vol. 1 № 8. -R 57-62.

  3. Goryanova A.B., Semenova N.A. Assessment of the rates of psychomotor development of children with Down syndrome. // Bulletin of the Russian State Medical University. Special issue. - 2013.-№. 1, -R.311.

  4. Zhiyanova P.L., Polya E.V. Baby with Down syndrome: A book for parents. - Ed. 4-E. - M.: Charity Foundation "Downside-Up”, 2015. - R 195.

  5. Kolcheva Yu.A. Pathogenetic foundations of neurological disorders in Down syndrome. BISSA 2017ю Vol. 6 -№. 4. -P. 19-21.

  6. Medvedeva T.P. Development of cognitive activity of children with Down syndrome: manual. M.: Monolit, 2010 - R 80.

  7. Odinikova G.Yu. Identification and overcoming of problems in the development of communication between a mother and a young child with Down syndrome: abstract. diss. ... cand. Psychological sciences: 13.00.03. - Moscow, 2015. - P. 26.

  8. Bain S. K., Allin J. D. Book review: Stanford-Binet intelligence scales, fifth edition. Journal of Psycho educational Assessment. -2003. -№23. -R 87-95.

  9. Raitano Lee N., Pennington B.F., Keenan J.M. Verbal short¬term memory deficits in Down syndrome: phonological, semantic, or both? J Neurodev Disord. -2010. -Vol. 2. №1. -R.9-25.

  10. Jensen K.M. Primary care for adults with Down syndrome: adherence to preventive healthcare recommendations. J Intellect Disabil Res. -2013. Vol. 57. -№5. -P.409-421.

  11. Ktosowska A. Down syndrome, increased risk of dementia and lipid disturbances. Dev Period Med. -2017. Vol. 21. -№1. -R 69-73.

  12. Hankinson T.C. Craniovertebral function abnormalities in Down syndrome. Neurosurgery. -2010. - Vol. 66. №3. -P.32-38,

  13. Sullivan W.F. Primary care of adults with intellectual and developmental disabilities: 2018 Canadian consensus guidelines. Can Fam Rhysician. -2018. -64. -№4. -R 254¬279,

  14. Bunt C.W. Role of the family physician in the care of children with Down syndrome. Am Fam Physician. -2014. Vol. 90. -№12. -R851-858,

  15. Bull M.J. Health supervision for children with Down syndrome. Pediatrics. 2011. -Vol. 128, -№ 2393-406,

  16. Lau WL et al: Prevalence and parental awareness of hearing loss in children with Down syndrome. Chin Med J (Engl). -2015. -128 -№8. P.1091-1095.

  17. Ilyina M.N. Psychological assessment of intelligence in children. Textbook. 2006.

  18. Association for Children With Down Syndrome: Association for Children With Down Syndrome website. Accessed June 1, 2020. http://www.acds.org/

  19. Norton M.E., et. al.: Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med. -2015. -№372: -P. 1588-1599.

  20. Baum R.A., Nash P.L., Foster J.E.A. Primary care of children and adolescents with Down syndrome: an update. Curr Probl Pediatr Adolesc Health Care. -2008. -№38. -P. 235-268.

  21. De la Torre R., de Sola S., Hernandez G. Safety and efficacy of cognitive training plus epigallocatechin-3- gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomizes, placebo-controlled, phase 2 trial. Lancet Neurol. -2016. -№ 15. -P. 801-810.

  22. Van Gameren-Oosterom H.B.M., Fekkes M., van Wouwe J.P., Problem behavior of individuals with Down syndrome in a nationwide cohort assessed in late adolescence. J Pediatr. -2013. -Vol. 163. -P. 1396-1401.

  23. Verstegen R.H.J., Chang K.J.J., Kusters M.A.A. Clinical implications of immune-mediated diseases in children with Down syndrome. PediatrAllergyImmunol. -2020. -Vol. 31. №2. -P. 117-123. doi: 10.1111/pai.13133. Epub 2019 Oct 25.

Mualliflar haqida

S.M. Salikhova
salikhova@mail.ru
Ташкентский Педиатрический медицинский институт Ташкент, Узбекистан
Y.N. Majidova
salikhova@mail.ru
Национальный детский медицинский центр

Qanday iqtibos keltirish kerak

КЛИНИКО-НЕВРОЛОГИЧЕСКИЕ И НЕЙРОФИЗИОЛОГИЧЕСКИЕ ИЗМЕНЕНИЯ У ДЕТЕЙ С ТРИСОМИЕЙ 21 ХРОМОСОМЫ. (2022). Bolalar Milliy Tibbiyot Markazining Axborotnomasi, 2, 67-71. https://hnchmc.uz/jour/article/view/13

O'xshash maqolalar

Siz ham ushbu maqola uchun {$ advancedSearchLink} olishingiz mumkin.

ISSN 2181-3353 (Print)
ISSN 2181-3353 (Online)